+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Amines 1130155-48-4
1130155-48-4,MFCD03695466
Catalog No.:AA008T6Q

1130155-48-4 | (E)-4-(diMethylaMino)but-2-enoic acid (Hydrochloride)

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
98%
in stock  
$38.00   $27.00
- +
5g
98%
in stock  
$128.00   $89.00
- +
10g
98%
in stock  
$213.00   $149.00
- +
25g
98%
in stock  
$444.00   $311.00
- +
100g
98%
in stock  
$1,517.00   $1,062.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA008T6Q
Chemical Name:
(E)-4-(diMethylaMino)but-2-enoic acid (Hydrochloride)
CAS Number:
1130155-48-4
Molecular Formula:
C6H12ClNO2
Molecular Weight:
165.6180
MDL Number:
MFCD03695466
SMILES:
CN(C)CC=CC(=O)O.Cl
Properties
Computed Properties
 
Complexity:
118  
Covalently-Bonded Unit Count:
2  
Defined Bond Stereocenter Count:
1  
Heavy Atom Count:
10  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
3  

Downstream Synthesis Route

[1]CurrentPatentAssignee:SUZHOUMIRACPHARMATECHNOLOGYCOLTD-CN110963972,2020,ALocationinpatent:Paragraph0042-0043

[2]Tsou,Hwei-Ru;Overbeek-Klumpers,ElsebeG.;Hallett,WilliamA.;Reich,MarvinF.;Floyd,M.Brawner;Johnson,BernardD.;Michalak,RonaldS.;Nilakantan,Ramaswamy;Discafani,Carolyn;Golas,Jonathan;Rabindran,SridharK.;Shen,Ru;Shi,Xiaoqing;Wang,Yu-Fen;Upeslacis,Janis;Wissner,Allan[JournalofMedicinalChemistry,2005,vol.48,#4,p.1107-1131]

[3]CurrentPatentAssignee:PFIZERINC-WO2005/34955,2005,A1Locationinpatent:Page/Pagecolumn12-13

[4]CurrentPatentAssignee:PFIZERINC-WO2005/34955,2005,A1Locationinpatent:Page/Pagecolumn13

[5]CurrentPatentAssignee:PFIZERINC-WO2005/34955,2005,A1Locationinpatent:Page/Pagecolumn13-14

[6]Locationinpatent:experimentalpartRode,HaridasB.;Sos,MartinL.;Grütter,Christian;Heynck,Stefanie;Simard,JeffreyR.;Rauh,Daniel[BioorganicandMedicinalChemistry,2011,vol.19,#1,p.429-439]

[7]CurrentPatentAssignee:ABBVIEINC-US8377946,2013,B1Locationinpatent:Page/Pagecolumn119;121

[8]Wu,Jianwei;Chen,Wenteng;Xia,Guangxin;Zhang,Jing;Shao,Jiaan;Tan,Biqin;Zhang,Chunchun;Yu,Wanwan;Weng,Qinjie;Liu,Haiyan;Hu,Miao;Deng,Hailin;Hao,Yu;Shen,Jingkang;Yu,Yongping[ACSMedicinalChemistryLetters,2013,vol.4,#10,p.974-978]

[9]CurrentPatentAssignee:ASTELLASPHARMAINC.-US2014/323463,2014,A1Locationinpatent:Paragraph0430

[10]CurrentPatentAssignee:DANA-FARBERCANCERINSTITUTE-WO2015/6492,2015,A1Locationinpatent:Page/Pagecolumn88

[11]Engel,Julian;Richters,André;Getlik,Matthäus;Tomassi,Stefano;Keul,Marina;Termathe,Martin;Lategahn,Jonas;Becker,Christian;Mayer-Wrangowski,Svenja;Grütter,Christian;Uhlenbrock,Niklas;Krüll,Jasmin;Schaumann,Niklas;Eppmann,Simone;Kibies,Patrick;Hoffgaard,Franziska;Heil,Jochen;Menninger,Sascha;Ortiz-Cuaran,Sandra;Heuckmann,JohannesM.;Tinnefeld,Verena;Zahedi,RenéP.;Sos,MartinL.;Schultz-Fademrecht,Carsten;Thomas,RomanK.;Kast,StefanM.;Rauh,Daniel[JournalofMedicinalChemistry,2015,vol.58,#17,p.6844-6863]

[12]Romu,AireenA.;Lei,Zining;Zhou,Bin;Chen,Zhe-Sheng;Korlipara,Vijaya[BioorganicandMedicinalChemistryLetters,2017,vol.27,#21,p.4832-4837]

[13]CurrentPatentAssignee:MSNLABORATORIESPRIVATELIMITED-US2018/297989,2018,A1Locationinpatent:Paragraph0246;0249;0263

[14]CurrentPatentAssignee:LENGOTHERAPEUTICSINC;JUBILANTPHARMOVALTD-WO2021/62327,2021,A1Locationinpatent:Paragraph0280

[15]CurrentPatentAssignee:SANOFI-EP3892614,2021,A1Locationinpatent:Paragraph0064

[16]CurrentPatentAssignee:SHAANXINORMALUNIVERSITY-CN114181217,2022,ALocationinpatent:Paragraph0162-0163;0166

[17]CurrentPatentAssignee:SCORPIONTHERAPEUTICS-WO2022/76831,2022,A2Locationinpatent:Page/Pagecolumn938

[1]Wissner,Allan;Fraser,HeidiL.;Ingalls,CharlesL.;Dushin,RussellG.;Floyd,M.Brawner;Cheung,Kinwang;Nittoli,Thomas;Ravi,MaliniR.;Tan,Xingzhi;Loganzo,Frank[BioorganicandMedicinalChemistry,2007,vol.15,#11,p.3635-3648]

[2]CurrentPatentAssignee:PFIZERINC-WO2005/115145,2005,A2Locationinpatent:Page/Pagecolumn159

212776-19-7   
(E)-4-(dimethylamino)-2-butenoicacidhydrochloride 

[1]CurrentPatentAssignee:TIANJININTJOINTACADEMYBIOMEDICINE-CN107556289,2018,ALocationinpatent:Paragraph0112;0123;0124;0125

[2]CurrentPatentAssignee:BAYERAG-WO2009/33581,2009,A1Locationinpatent:Page/Pagecolumn58

[3]CurrentPatentAssignee:PFIZERINC-US2003/50222,2003,A1

[4]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2016/91916,2016,A1Locationinpatent:Page/Pagecolumn93

848139-78-6   
(E)-4-(dimethylamino)-2-butenoicacidhydrochloride 
  698387-09-6 

[1]Patent:US2006/270669,2006,A1.Locationinpatent:Page/Pagecolumn19

[1]CurrentPatentAssignee:BAYERAG-US2010/298297,2010,A1Locationinpatent:Page/Pagecolumn12;21

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 1130155-48-4
7147-44-6

7147-44-6

 2564-94-5

2564-94-5

 149586-32-3

149586-32-3

 98548-82-4

98548-82-4

 1259519-60-2

1259519-60-2

 1092365-58-6

1092365-58-6
Building Blocks
More >
Tags:1130155-48-4 Molecular Formula|1130155-48-4 MDL|1130155-48-4 SMILES|1130155-48-4 (E)-4-(diMethylaMino)but-2-enoic acid (Hydrochloride)